注射用单磷酸阿糖腺苷专项处方点评干预的成效分析  被引量:2

Analysis on Effectiveness of Special Prescription Comment on Vidarabine Monophosphate for Injection

在线阅读下载全文

作  者:钟文 黄艳[1] 周峰[2] ZHONG Wen;HUANG Yan;ZHOU Feng(Children's Hospital Affiliated to Suzhou University,Suzhou Jiangsu 215021,China;Suzhou No.5 People's Hospital,Suzhou Jiangsu 215007,China)

机构地区:[1]苏州大学附属儿童医院,江苏苏州215025 [2]苏州市第五人民医院,江苏苏州215007

出  处:《抗感染药学》2019年第11期1863-1866,共4页Anti-infection Pharmacy

摘  要:目的:分析并建立注射用单磷酸阿糖腺苷专项处方点评模式,加强处方合理使用点评与管理,为临床儿童安全、合理用药提供参考。方法:抽取2016年6月份医院门诊所有含注射用单磷酸阿糖腺苷的门诊处方,按照《处方管理办法》、《医院处方点评管理规范(试行)》的要求由药师对处方进行初步的分析点评,将点评结果提交医院处方点评专家组讨论,最后点评结果由点评专家组交由医务处进行公示;另抽取2016年10月按照相同标准点评专项处方进行效果确认。结果:经过专项处方点评公示配合医院行政处理4月后,注射用单磷酸阿糖腺苷的单药处方数由整治前的546张降为整治后的230张,单磷酸阿糖腺苷使用合格率由整治前的1.10%提高至整治后的24.34%,该药使用合理性得到明显改善。结论:基于处方专家组的专项处方点评模式结合行政奖惩制度的有效落实,提高了医院的处方合格率,但目前仍然着眼于事后点评,仍需进一步健全医院信息化建设,加强处方前置审核的地位,以确保患者用药的安全性和有效性。Objective:To analyze and establish a prescription evaluation model of vidarabine monophosphate, to strengthen the management of rational use, and to provide a reference for safe and rational drug use in clinical children.Methods:A total sample of outpatient prescriptions containing vidarabine monophosphate were selected from June to October 2016. According to the requirements of "Prescription Management Measures" and "Hospital Prescription Review Management Standards"(trial implementation), pharmacists made a retrospective review of the prescriptions and submitted the results to the Hospital Prescription Review Expert Group. After discussion, the final result will be handed over to the Medical Department for publicity and punishment. Results:After 4 months of prescription evaluation and public announcement combined with hospital administrative treatment, the number of single prescription of vidarabine monophosphate decreased from 546 before treatment to 230 after treatment, and the qualified rate of vidarabine monophosphate prescription use increased from 1.10% before treatment to 24.34% after treatment. The rationality of the drug use was improved significantly. Conclusion:The special prescription evaluation model based on expert group and the effective reward and punishment system improved the prescription rational rate, but at present we still had to focus on post-comment. It is necessary to improve the hospital informatization and focus on the pre-prescription auditing so as to ensure the safety and effectiveness of the patient medication.

关 键 词:注射用单磷酸阿糖腺苷 专项处方点评 合理用药 成效分析 

分 类 号:R969.3[医药卫生—药理学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象